The current review provides an update on secreted factors and mechanisms that promote a thermogenic program in beige adipocytes, and their potential roles as therapeutic targets to fight obesity.
INTRODUCTION
Obesity and consequent metabolic disorders, such as type 2 diabetes, are an increasingly serious global health problem and reflect a need for more comprehensive and effective strategies for prevention, treatment, and even reversal. Given that obesity results when bodily energy intake exceeds expenditure, one potential solution would be to increase energy expenditure. Indeed, tunable strategies to minimally enhance energy expenditure over prolonged periods of time could both prevent and potentially reverse obesity without substantial risk for unwanted off-target effects. This review discusses several avenues of progress towards this goal.
Adipose tissue maintains the critical balance between lipid storage and utilization for energy. Two basic types of adipose tissue have been identified -white adipose tissue (WAT), which is responsible for storage of excess triglycerides, and brown adipose tissue (BAT), which is specialized to dissipate energy by producing heat. One key difference between WAT and BAT is that the latter expresses uncoupling protein-1 (UCP1), a transmembrane protein in mitochondria that is responsible for heat generation.
Additionally, precursor cells existing mainly within subcutaneous WAT depots can be stimulated to differentiate into thermogenic 'beige' or 'brite' adipocytes [1] [2] [3] . Conversion to a thermogenic phenotype or 'beiging' in these cells can be triggered by cold exposure and by b3-adrenergic receptor or peroxisome proliferator-activated receptor g (PPARg) agonists, promoting UCP1 expression and b-oxidation, and uncoupled respiration [1, 2] . Activated beige adipocytes burn free fatty acids to generate heat similar to a bona fide brown adipocyte within the BAT [2, 4] . Although it is estimated that beige adipocytes only contribute about one-fifth of the thermogenic capacity generated by BAT, at least in rodents, their physiological contribution to energy homeostasis and systemic metabolism is still important [4] . Stimulating WAT beiging increases energy expenditure, produces antiobesity effects, and improves glucose tolerance and insulin sensitivity in several mouse models [2] [3] [4] . Moreover, the recruitable nature of beige cells operant within the WAT makes them attractive therapeutic targets, prompting interest in the factors and pathways regulating their number and function.
CLINICAL RELEVANCE OF BEIGE ADIPOSE TISSUE
With the goal of identifying factors capable of inducing WAT beiging to treat metabolic disorders, the important question is whether humans are capable of such a phenomenon. Several studies have now identified that classical 'brown' adipocytes and recruitable beige adipocytes differentiate from distinct developmental lineages and exhibit distinct gene expression signatures [5, 6] . Humans are born with BAT located in the interscapular region that contains adipocytes expressing the classical brown profile [7, 8] . This BAT involutes over the next several months, and traditional thinking held that humans, unlike rodents, are devoid of true BAT after the newborn period [9] . However, more recent metabolic tracer studies using PET imaging demonstrate that adult human participants have considerably sized depots of metabolically active adipose tissue that avidly take up glucose [10, 11] . Indeed, it is now known that thermogenic fat stores increase within the body over the first decade of life, and in response to puberty [12, 13] .
Adult human BAT, however, exhibits differences when compared with newborn human BAT or interscapular BAT in adult rodents. First, the thermogenic capacity of adult BAT is highly inducible by cold and adrenergic stimulation [14, 15] . Indeed, several studies on human subjects have shown that daily, mild (e.g. 19 8C), short-term (2 h) cold exposure increases energy expenditure, reduces fat mass, and improves insulin sensitivity in association with activation of intra-thoracic BAT [15, 16] . Consistent with this, BAT mass is higher in adult humans who live in cold climates, and in the winter versus summer [17] . Moreover, the amount and activity of adult BAT is decreased in obese individuals [2, 18] . Taken together, this information highlights the energetic and metabolic importance of adult human BAT, and the potential clinical benefit of developing strategies to promote BAT recruitment and thermogenic activation.
The functional differences between the BAT of adult humans and rodents have been probed at the cellular level. This work revealed that adipocytes from supraclavicular fat, which was thought to represent classical BAT, in fact express a gene profile reminiscent of beige adipocytes [1] [2] [3] . Genomewide analysis shows that UCP1 þ adipocytes derived from human BAT samples display a transcriptional profile more similar to murine beige adipocytes than classical interscapular brown adipocytes. Thus, human adult 'BAT' depots are in fact mainly constituted of beige-like adipocytes that are competent for ligand-stimulated activation [5] . This conclusion has led to a proliferation of research focused on finding secreted factors that control the beiging process.
SECRETED FACTORS MODULATE BEIGE ADIPOCYTE ACTIVATION
Space limitations preclude us from discussing all the signaling molecules regulating beige adipogenesis and function here. Several of these have already been reviewed [3, 19] . Instead, we will focus specifically on endogenously synthesized and physiologically important secreted factors that may be effectively targeted from a therapeutic standpoint.
Secreted factors and their corresponding receptors have become attractive therapeutic targets against metabolic diseases because by manipulating endogenous endocrine, paracrine, and/or autocrine pathways that are already in place, we may achieve clinically relevant outcomes without all the undesirable off-target effects associated with traditional drug discovery. For example, catecholamines acting via the b3-adrenergic receptor directly stimulate the classical pathway that activates beige adipocytes. However, developing adrenergic ligands for obesity and metabolic disease applications could produce
KEY POINTS
Human beings have a substantial reservoir of beige adipocytes that can be recruited to enhance energy expenditure; targeting these cells represents a clear opportunity to improve metabolic health.
The identification of unrecognized endogenous factors that promote beiging offer new potential avenues for therapeutic engineering targeting obesity and related metabolic disorders.
Recent studies have identified UCP1-independent pathways that promote beige adipogenesis, thermogenesis, and/or conversion between beige and white adipocyte phenotypes, highlighting the complexity of adipose tissue energetics and the number of different strategies that may be leveraged for clinical purposes.
unwanted autonomic, bone, and cardiovascular effects over time. Similarly, bone morphogenetic proteins 4, 7, and 8b (BMP4, BMP7, BMP8b), atrial and brain-type natriuretic peptides, FGF21, VEGF-A, and prostaglandins, have all been shown to promote beiging in vivo [20] [21] [22] [23] [24] [25] . However, these factors may also exert potentially unwanted pleiotropic effects when translated into drugs. Indeed, the development of FGF21 mimetics was halted after phase I trials because of adverse effects [26] . By contrast, several more recently identified endogenous factors show promise as beiging agents and examination of their therapeutic potential is thus continuing aggressively. Below we summarize intriguing endogenous secreted factors identified in the last 2 years and discuss their therapeutic potential.
Slit2
Slit2 is a factor secreted by beige adipocytes under transcriptional control of PRDM16, a master-regulator of beige/brown adipocyte differentiation [27 & ]. Slit2 is posttranslationally cleaved, and functional studies reveal that the C-terminal fragment of Slit2 promotes thermogenesis cultured white adipocytes and in mice by activating the PKA-p38 MAP kinase pathway ( Fig. 1) 
Interestingly, adenoviral overexpression of Cterminal Slit2 in the livers of diet-induced obese mice increased whole-body energy expenditure and improved glucose tolerance, suggesting that systemically administering purified Slit2 C-terminal protein in isolation could produce beneficial effects [27 & ]. Previous studies showed that Slit proteins bind to the Robo family of receptors through their Nterminal region to activate the small GTPase Cdc42 [28] , whereas the receptor for the C-terminus of Slit2 is unknown. Notably, although full-length Slit2 also promotes beiging, the truncated C-terminal Slit2 protein might provide a more specific effect therapeutically.
Angiopoietin-like 4
Angiopoietin-like 4 (ANGPTL4) is a secreted protein highly expressed in liver and adipose tissues, whose FIGURE 1. Newly discovered pathways in the physiology of beige adipocytes. Shown are several recently identified endogenous secreted factors that regulate beige thermogenesis. Note that these factors, acting via recognized and as yet unknown receptors, converge primarily onto the PKA-p38MAPK and ERK-signaling pathways. Interestingly, two of these factors, Slit2 and ANGPTL4, are cleaved, with the pro-thermogenic domain of each protein being confined to the C-terminal fragment. These factors have been shown to augment classical (UCP1-dependent) uncoupling to produce metabolically desirable effects. Shown also are UCP1-independent pathways recently found to operate in beige adipocytes as well. These include thermogenesis resulting from futile calcium cycling into and out of intracellular stores, Parkin-dependent mitophagy during beige-to-white adipocyte interconversion, and futile creatine cycling within the mitochondrial outer matrix. These factors and pathways greatly expand the number of potential therapeutic targets that may be exploited to reverse obesity and associated metabolic diseases. UCP-1, uncoupling protein-1.
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expression is induced by environmental cues including fasting, hypoxia, and glucocorticoids. As with Slit2, ANGPTL4 has distinct structural and functional domains corresponding with its Nterminal and C-terminal halves. Initial studies of ANGPTL4 focused on its ability to inhibit lipoprotein lipase, an activity that is specifically exerted by its N-terminal coiled-coil domain (CCD) [29] . However, ANGPTL4 also promotes intracellular triacylglycerol hydrolysis (lipolysis) in adipocytes by stimulating cAMP production (Fig. 1) [30] . This action is independent of the CCD, and is now known to be exerted specifically by the C-terminal fibrinogen-like domain (FLD) of ANGPTL4 [31 & ]. Increasing circulating ANGPTL4 FLD levels in isolation induced in-vivo adipose tissue lipolysis, protected mice against high-fat diet-induced obesity, ectopic steatosis, and glucose intolerance [31 & ]. In addition, ANGPTL4 FLD increased oxygen consumption and the expression of thermogenic genes, such as UCP1 and PGC-1a, in inguinal WAT, an indication of beiging [31 & ]. These effects resulted in increased whole-body energy expenditure [31 & ]. The receptor mediating ANGPTL4 FLD effects on adipocytes is unknown, however, previous studies showed that ANGPTL4 FLD associates with integrins, including b1, b3, and b5, to stimulate cell migration and apoptosis in cancer cells and keratinocytes [29] . The role of integrin-dependent signaling in ANGPTL4 FLD-induced beiging, however, is unclear. Although full-length ANGPTL4 also likely induces beiging, the C-terminal ANGPTL4 FLD could be more beneficial therapeutically, as administering it would avoid the inhibition of lipoprotein lipase and consequent hypertriglyceridemia stimulated by the N-terminal CCD [10] . 35] . However, ADM2 also impacts the cardiovascular system and can produce hypotension in animal models [33] . Therefore, targeting ADM2-dependent signaling to curb obesity will require a strategy to do so in a WATspecific manner.
Adrenomedullin 2

Kynurenic acid
Kynurenine is a neurotoxic metabolite of tryptophan [36] . Exercise increases conversion of kynurenine to kynurenic acid in skeletal muscle and in the circulation [ 
TGR5
TGR5 is a G protein-coupled receptor for bile acids [38] , and cold-induced WAT beiging was attenuated in TGR5-deficient mice [39 & ]. Under thermoneutral conditions, at which there is no ambient temperature-associated thermogenic stress, activating TGR5 with systemic TGR5-selective bile acid mimetics promotes subcutaneous WAT beiging in wild-type, but not TGR5-null mice [39 & ]. Not surprisingly, TGR5-selective bile acid mimetics also induce beiging and reduce body weight gain in mice with diet-induced obesity [39 & ]. Adding the TGR5 agonist INT-777 to differentiation media bathing adipogenic precursor cells from the WAT stromal vascular fraction of wild-type mice augmented the expression of thermogenic genes [39 & ]. INT-777 was shown to induce mitochondrial fission and respiration in an ERK/DRP1-dependent manner (Fig. 1) [39 & ]. Although TGR5 is a potentially desirable therapeutic target, TGR5 agonists also produce several unwanted effects as well, including gallbladder expansion, impaired immune function, and alterations in heart rate [40, 41] . These off-target effects could limit the development of TGR5-based therapies. As such, any potential antiobesity approach focused on TGR5 may have to be engineered to be WAT specific.
Immune signals
Group 2 innate lymphoid cells (ILC2s) and M2 macrophages remain an active focus in metabolic research [32 & ,34] , though the specific role of macrophages in catecholamine metabolism has been recently questioned [42] . A recent study found that FGF21 activates type 2 immunologic responses in the WAT by inducing adipocytes to express the chemokine CCL11 [43] . Moreover, the activation of histamine receptor has been shown to induce PKA signaling, leading to UCP1 expression and subcutaneous WAT beiging [44] . In targeting immune signals to stimulate beiging, however, effective strategies will require that this targeting is specific to the WAT and/or BAT, and to metabolic and temperature-sensitive triggers, to lessen the possibility of either autoimmunity or immunosuppression in a broader sense.
NEW INSIGHTS ON BEIGE ADIPOCYTE PHYSIOLOGY
Most studies of secreted factor effects on beige adipocyte differentiation and physiology use rodent models. Notably, as we discussed above, there are differences between rodent and human BAT and they could respond to secreted factors differently. Recent studies show that human BAT is activated by acute glucocorticoid treatment, whereas in rodent BAT, glucocorticoids significantly suppress thermogenesis [45] . Moreover, human BAT does not respond to certain b3-adrenergic receptor agonists as well as rodent BAT [46] . Thus, it is important to establish human stem cell models to study the effects of secreted factors on beige adipocyte differentiation. Recently, one group had success differentiating human pluripotent stem cells (hPSCs) through mesenchymal stem cells to thermogenically active adipocytes most closely, physiologically resembling beige adipocytes [47] . The current progress of developing human stem cell-based models of thermogenic adipocytes has been reviewed in a recent article [48] .
Most of the secreted factors described thus far promote beiging through activation of the cAMP-PKA pathway (Fig. 1) . Recent studies, however, have revealed additional, previously unrecognized physiological pathways that induce WAT beiging without altering the function of bona fide brown adipocytes. These pathways provide new directions in screening for secreted factors that promote beige differentiation and activation.
One such pathway underlies a UCP1-independent thermogenic mechanism newly identified in beige adipocytes residing in WAT, which express UCP1 at much lower levels than do brown adipocytes residing BAT. This discovery stemmed from the initial observation that mice lacking UCP1 contain beige adipocytes capable of thermogenesis [49 && ]. In these mice, enhanced ATP-dependent calcium cycling in beige adipocytes by the sarco/endoplasmic reticulum Ca 2þ -ATPase 2b (SERCA2b) and the type 2 ryanodine receptor (RyR2) promotes thermogenesis, whereas this pathway is expendable in BAT thermogenesis [49 && ]. The mechanism for this cell type specificity is unclear, but may hinge on the higher cellular availability of ATP in beige, as opposed to brown adipocytes [49 && ]. PKA enhances this thermogenic mechanism by phosphorylating RyR2, potentiating calcium release from the sarco/ endoplasmic reticulum.
Creatine metabolism has also been shown to play a role in maintaining thermogenesis independently of UCP1. The expression of genes regulating creatine metabolism was elevated in UCP1-deficient mice, and reducing creatine levels in these mice decreased core body temperature and oxygen consumption by WAT beige cells [50] . Reducing creatine levels also decreased cold-inducible and catecholamine-inducible energy expenditure in both WAT and BAT [50] .
Beige adipocytes spontaneously revert to a classical white-like phenotype, including development of hallmark unilocular lipid droplets, without the constant presence of stimuli to maintain their thermogenic phenotype [18] . This beige-to-white conversion may be because of autophagy-mediated mitochondrial degradation 
The identification of functionally important UCP1-independent thermogenic mechanisms employed by beige adipocytes expands the number of approaches targeting adipocytes to fight obesity (Fig. 1) . However, whereas enhancing Ca 2þ -cycling to promote thermogenesis could have therapeutic potential, forcing Ca 2þ -cycling in cells beyond adipocytes could have adverse effects on cardiac and skeletal muscle function. Thus, stimulating these UCP1-independent pathways in an adipose-specific manner is critical. Minimizing beige-to-white adipocyte conversion could be another approach to enhance beige adipocyte activity.
CONCLUSION
We have summarized some newly identified endogenous secreted factors that promote beige adipocyte activation. The identification of Slit2 and ANGPTL4, in this regard, are especially intriguing, as targeting specific functional domains of each of these factors may hold therapeutic promise without the adverse effects that might be attendant with the entire fulllength proteins. The identification of UCP1-independent mechanisms for adipose tissue thermogenesis and pathways governing beige-to-white adipocyte conversion provide alternative therapeutic avenues as well. Regardless, a key remaining task is confining the action of any beiging-oriented therapeutics specifically to the adipose tissue, and avoiding effects on tissues elsewhere in the body. 1R01DK1123 to S.K.K., and indirectly by NIDDK-sponsored P30 grants (DK098722 UCSF Nutrition and Obesity Research Center and DK063720 UCSF Diabetes Research Center). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
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There are no conflicts of interest. has identified a new 'whitening' mechanism in beige adipose tissue. They have shown that, upon warming, beige adipocytes exhibit a shift in cellular identity, namely a conversion from a brown to white chromatin state driven by a glucocorticoid receptor and Zfp423-dependent signaling cascade.
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